BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,977,618 | +2.6% | 15,392,319 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $106,233,945 | -14.1% | 15,090,049 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $123,649,783 | -24.2% | 14,826,113 | +4.4% | 0.00% | -25.0% |
| Q4 2022 | $163,066,455 | -6.5% | 14,204,395 | +2.6% | 0.00% | -20.0% |
| Q3 2022 | $174,366,000 | +19.3% | 13,838,612 | +0.2% | 0.01% | +25.0% |
| Q2 2022 | $146,112,000 | -32.0% | 13,810,173 | +4.6% | 0.00% | -20.0% |
| Q1 2022 | $214,746,000 | +64.7% | 13,207,040 | +40.3% | 0.01% | +66.7% |
| Q4 2021 | $130,369,000 | -3.2% | 9,412,905 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $134,747,000 | -8.4% | 9,377,048 | +0.8% | 0.00% | -25.0% |
| Q2 2021 | $147,105,000 | +49.1% | 9,304,543 | -4.1% | 0.00% | +33.3% |
| Q1 2021 | $98,648,000 | +14.2% | 9,700,067 | -16.4% | 0.00% | 0.0% |
| Q4 2020 | $86,415,000 | +119.1% | 11,599,334 | +1.0% | 0.00% | +200.0% |
| Q3 2020 | $39,444,000 | -23.9% | 11,483,032 | +5.5% | 0.00% | -50.0% |
| Q2 2020 | $51,859,000 | +195.6% | 10,883,542 | +24.1% | 0.00% | +100.0% |
| Q1 2020 | $17,544,000 | -37.4% | 8,772,116 | +8.0% | 0.00% | 0.0% |
| Q4 2019 | $28,020,000 | +63.6% | 8,121,631 | +35.8% | 0.00% | 0.0% |
| Q3 2019 | $17,128,000 | -32.5% | 5,978,921 | -10.7% | 0.00% | 0.0% |
| Q2 2019 | $25,365,000 | -48.4% | 6,692,444 | +10.7% | 0.00% | -50.0% |
| Q1 2019 | $49,194,000 | +3.8% | 6,043,507 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $47,389,000 | +7.1% | 5,872,229 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $44,240,000 | +45.5% | 5,798,229 | +9.2% | 0.00% | +100.0% |
| Q2 2018 | $30,414,000 | +12.5% | 5,307,910 | -6.3% | 0.00% | 0.0% |
| Q1 2018 | $27,026,000 | -4.7% | 5,665,757 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $28,369,000 | -9.9% | 5,777,835 | -3.8% | 0.00% | 0.0% |
| Q3 2017 | $31,477,000 | -5.8% | 6,007,083 | -0.0% | 0.00% | -50.0% |
| Q2 2017 | $33,404,000 | -20.7% | 6,007,815 | +19.9% | 0.00% | 0.0% |
| Q1 2017 | $42,098,000 | +97.9% | 5,011,763 | +49.1% | 0.00% | +100.0% |
| Q4 2016 | $21,272,000 | +35.6% | 3,360,471 | -5.5% | 0.00% | 0.0% |
| Q3 2016 | $15,684,000 | +56.6% | 3,556,486 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $10,016,000 | +9.1% | 3,526,530 | +8.7% | 0.00% | 0.0% |
| Q1 2016 | $9,179,000 | -68.3% | 3,243,328 | +15.5% | 0.00% | -50.0% |
| Q4 2015 | $28,989,000 | -90.9% | 2,809,038 | -76.5% | 0.00% | -83.3% |
| Q3 2015 | $318,368,000 | +763.4% | 11,928,347 | +383.0% | 0.01% | +500.0% |
| Q2 2015 | $36,873,000 | +65.9% | 2,469,727 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $22,224,000 | -20.0% | 2,461,182 | +7.7% | 0.00% | 0.0% |
| Q4 2014 | $27,778,000 | +37.5% | 2,284,328 | +10.6% | 0.00% | 0.0% |
| Q3 2014 | $20,207,000 | -22.7% | 2,066,137 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $26,128,000 | +38.4% | 2,049,252 | +14.8% | 0.00% | 0.0% |
| Q1 2014 | $18,881,000 | +42.5% | 1,784,623 | +2.4% | 0.00% | +100.0% |
| Q4 2013 | $13,251,000 | +9.5% | 1,743,427 | +4.9% | 0.00% | 0.0% |
| Q3 2013 | $12,098,000 | +383.7% | 1,661,785 | +3.0% | 0.00% | – |
| Q2 2013 | $2,501,000 | – | 1,613,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |